|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
a Department of Respiratory Medicine, Maidstone Hospital, Hermittage Lane, Maidstone, Kent ME16 9QQ, United Kingdom
b Department of Thoracic Surgery, Bristol Royal Infirmary, Bristol, B52 8HW United Kingdom
c Department of Respiratory Medicine, Severn Postgraduate School of Medicine, Bristol Royal Infirmary, Bristol, B52 8HW United Kingdom
(Email: dr_arshad_husain@yahoo.co.uk; anthony.morgan@ubht.nhs.uk; martin.hetzel@trantraweb.co.uk).
| The first 20% of the full text of this article appears below. |
To the Editor:
We thank Dr Foroulis and colleagues [1] for their interest in our article [2]. However, we believe that the issues raised in their letter are somewhat out of context with the messages in it.
In our series, we have only used Ultraflex endobronchial stents (Boston Scientific, Watertown, MA) in carefully selected patients with benign airway obstruction in whom conventional surgery was not an option. There was never any question of them being suitable for any other therapeutic procedure in the future, and they had severe symptoms; so the only choice for treatment was between expanding wire or silicone stents.
We
Related Article
Ann. Thorac. Surg. 2008 85: 1842-1843.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |